Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
European Journal of Pharmacology|April 29, 1992
In vivo binding to dopamine receptors: a correlate of potential antipsychotic activityR D McQuade, R A Duffy, V L Coffin, et al.Pharmacology, Biochemistry, and Behavior|January 1, 1992
Selective up-regulation of D-1 dopamine receptors following chronic administration of SCH 39166 in primatesR A Duffy, G Kaminska, R E Chipkin, et al.Journal of Chemical Neuroanatomy|July 7, 2000
In vivo autoradiography of [3H]SCH 39166 in rat brain: selective displacement by D1/D5 antagonistsR A Duffy, M A Hunt, J K Wamsley, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
In vivo binding of SCH 39166: a D-1 selective antagonistR D McQuade, R A Duffy, V L Coffin, et al.Pharmacology, Biochemistry, and Behavior|November 1, 1994
Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypesM A Tice, T Hashemi, L A Taylor, et al.Life Sciences|January 1, 1988
Serotonergic component of SCH 23390: in vitro and in vivo binding analysesR D McQuade, D Ford, R A Duffy, et al.The Pharmacogenomics Journal|September 29, 2004
Identification of single-nucleotide polymorphisms of the human neurokinin 1 receptor gene and pharmacological characterization of a Y192H variantG P Randolph, J S Simon, M G Arreaza, et al.Bioorganic & Medicinal Chemistry Letters|April 11, 2001
Design and synthesis of ether analogues as potent and selective M2 muscarinic receptor antagonistsY Wang, S Chackalamannil, W Chang, et al.Journal of Neurochemistry|December 1, 1991
[3H]SCH 39166, a new D1-selective radioligand: in vitro and in vivo binding analysesR D McQuade, R A Duffy, C C Anderson, et al.Bioorganic & Medicinal Chemistry Letters|October 31, 2000
Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonistsY Wang, S Chackalamannil, Z Hu, et al.Pageof 2